HEPATITIS C ANTIVIRAL COMPOSITIONS COMPRISING 5-(1-METHYLPYRAZOL-4-YL)2- NAPHTHOYLGUANIDINE AND 2-C-METHYLADENOSINE OR 2-C-METHYLCYTIDINE 5-(1--4-)2- 2-C- 2-C-

摘要

The present invention relates to novel compositions having anti-viral activity and in particular it relates to synergistic compositions active against Hepatitis C virus (HCV). The invention also relates to methods for retarding, reducing or otherwise inhibiting HCV growth and/or functional activity.